Back to search

Article

Pre- and post-surgery change of EGFR mutation status in a lung squamous cell cancer patient

2021-04-01

Abstract excerpt

<h4>Background: </h4> The percentage of epidermal growth factor receptor (EGFR) mutations in squamous lung cancer was relatively low. The dynamic changes of EGFR mutation in peripheral blood before and after surgical resection in epidermal growth factor receptor (EGFR) has been rarely reported.Case presentationWe report a 73-year-old woman with squamous lung cancer of the left upper lobe and EGFR exon 19 deletion...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
771a5c25-4235-5157-a640-d122607ad4ae
DOI
10.21203/rs.3.rs-335690/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pre- and post-surgery change of EGFR mutation status in a lung squamous cell cancer patientDOI 10.21203/rs.3.rs-335690/v1
Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIsSemantic proximity
Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patientsSemantic proximity
A case of different gene mutations in primary and metastatic lesions after EGFR-TKI treatment of lung cancer.Semantic proximity
Different subtypes of EGFR exon19 mutation can affect prognosis of patients with non-small cell lung adenocarcinomaSemantic proximity
A regional analysis of epidermal growth factor receptor (EGFR) mutated lung cancer for HSE South.Semantic proximity
Non-small cell lung cancer patients with ex19del or exon 21 L858R mutation: distinct mechanisms, different efficacies to treatments.Semantic proximity
Biological difference between L858R and exon 19 deletion contributes to recurrence-free survival of resected non-small cell lung cancerSemantic proximity
Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21Semantic proximity
Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first-line tyrosine kinase inhibitors: A single-center ambispective cohort study.Semantic proximity
Prognostic implication of EGFR mutation status and subtype in resected lung adenocarcinoma patients irrespective of therapy.Semantic proximity
[Clinical characteristics and outcomes of lung cancer patients with EGFR mutations in exons 19 and 21].Semantic proximity
An association of epidermal growth factor receptor mutation subtypes with prognostic prediction and site-specific recurrence in advanced stage lung cancer patients.Semantic proximity
Select a neighboring publication to make it the new centre.